新疆313例维汉老年胰腺癌患者预后分析

doi:10.11904/j.issn.1002-3070.2016.01.001

实用肿瘤学杂志 ›› 2016, Vol. 30 ›› Issue (1): 1-6.doi: 10.11904/j.issn.1002-3070.2016.01.001

• 论著 • 下一篇

新疆313例维汉老年胰腺癌患者预后分析

裴磊, 才层, 毛睿, 艾力江·吐尔逊, 赵化荣, 张华, 包永星

新疆医科大学第一附属医院肿瘤中心(乌鲁木齐 830054)

收稿日期:2015-08-07 出版日期:2016-02-28 发布日期:2016-02-25
通讯作者: 包永星,E-mail:baoyx@vip.sina.com
作者简介:裴磊,男,(1989-),硕士研究生,从事消化道肿瘤综合治疗的研究
基金资助:
乌鲁木齐市科技局项目(y141310033)

Prognostic analysis of 313 aged pancreatic cancer patients in hospital treatment between Uygur and Han nationality in Xinjiang area

PEI Lei, CAI Ceng, MAO Rui, Ailijang.Tu-er-xun, ZHAO Huarong, ZHANG Hua, BAO Yongxing

The Center for Irradiation Therapy,The First Affiliated Hospital of Xinjang Medical University,Urumqi 830054,China

Received:2015-08-07 Online:2016-02-28 Published:2016-02-25

摘要/Abstract

摘要： 目的探讨影响新疆维汉老年胰腺癌患者(≥60岁)生存时间的预后因素。方法对本院2003年1月1日—2015年5月30日资料完整的313例老年胰腺癌患者进行回顾性研究。采用Kaplan-Meier法计算生存率,Log-rank检验影响预后的单因素分析,符合条件的纳入Cox比例风险模型进行多因素分析。结果 313例老年胰腺癌患者中位生存时间为157天,0.5、1、2年生存率分别为34.8%、18.5%、7.0%。其中维汉两民族之间生存时间具有统计学差异(P＜0.001)。单因素分析显示,民族、ECOG评分(ZPS)、临床分期(TNM)、肿瘤大小、肿瘤部位、是否行手术治疗及行根治性手术、放化疗、治疗前CEA水平、CA199水平与胰腺癌患者的长期生存有关,Cox多因素分析则显示,临床分期、手术治疗及手术方式可作为独立影响预后因素(P＜0.05)。结论临床分期(TNM)、手术治疗及手术方式可作为胰腺癌预后独立因素。无论汉族还是维吾尔族老年患者,及早地发现及及早行根治性手术是目前延长老年胰腺癌患者生存时间的关键。

关键词: 胰腺癌, 老年, 预后, 单因素分析, 多因素分析

Abstract: Objective To investigate the prognostic factors of survival time of the Uygur and Han nationality elderly patients(over 60 years)with pancreatic cancer in Xinjiang.Methods We carried on a retrospective study of 313 aged patients diagnosed with pancreatic cancer in The First Affiliated Hospital of Xinjiang Medical University from January 1st,2003 to May 30th,2015.We used Kpalan-Meier method for calculation of survival,used Log-rank method for those factors which could affect the prognosis of patients,at last we used Cox proportional risk model for those multiple factors which match the role.Results Three hundred and thirteen cases with pancreatic cancer had a median survival of 157 days,and survival rates of half a year,1 and 2 year were 34.8%,18.5%,7.0%.There was a statistic difference between Uygur patients′ and Han patients′ survival time(P＜0.05).Single factor analysis showed the nationality,tumor size,surgery,ZPS(ECOG),Clinical stage(TNM),chemotherapy and radiotherapy,carcino-embryonic antigen(CEA)level and cancer antigen 199(CA199)level before treatment with outcome(P＜0.05).Multiple factor analysis showed that the clinical stage,surgery(P＜0.05)can be regarded as independent prognostic decision factors.Conclusion The clinical staging,surgical treatment could be regarded as independent prognostic factors for the elderly prognosis of pancreatic cancer.Both of the Han and Uygur patients,earlier discovered and more appropriate surgery treatment are the key for the elderly patients with pancreatic cancer.

Key words: Pancreatic cancer, Aged, Survival, Single factor analysis, Multiple factor analysis

中图分类号:

R735.9

裴磊, 才层, 毛睿, 艾力江·吐尔逊, 赵化荣, 张华, 包永星. 新疆313例维汉老年胰腺癌患者预后分析[J]. 实用肿瘤学杂志, 2016, 30(1): 1-6.

PEI Lei, CAI Ceng, MAO Rui, Ailijang.Tu-er-xun, ZHAO Huarong, ZHANG Hua, BAO Yongxing. Prognostic analysis of 313 aged pancreatic cancer patients in hospital treatment between Uygur and Han nationality in Xinjiang area[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(1): 1-6.

参考文献

1 Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
2 Siegel R,Naishadham D,Jemal A.Cancer statistics[J].CA Cancer J Clin,2013,63(1):11-30.
3 中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南(2014)[J].中华外科杂志,2014,52(12):881-887.
4 Jung Y,Lee S,Choi HS,et al.Clinical validation of colorectal cancer biomakers identified from bionformations analysis of public expression date[J].Clin Cancer Res,2011,17(4):700-709.
5 Sigal V,Singal AK,Kuo YF.Racial dispariries in treatment for pancreatic cancer and impact on survival:a population-based analysis[J].J Cancer Res Clin Oncol,2012,138(4):715-722.
6 张宏武,蒋升,徐焱成.新疆维吾尔族、哈萨克族和汉族糖尿病前期人群血清尿酸及代谢综合征分布的横断面研究[J].中华流行病学杂志,2013,34(10):958-960.
7 王育璠,赵立,顾鸣宇,等.胰腺癌与糖尿病关联的探讨[J].中国癌症杂志,2006,16(11):973-975.
8 Chang CK,Ulrich CM.Hyperinsulinacmia and hyperglycaemia:possible risk factors of colorectal cancer among diabetic patients[J].Diabctologia,2003,46(5):595-607.
9 Weber A,Kehl V,Mittermeyer T,et al.Prognostic factors for survival in patients with unresectable pancreatic cancer[J].Pancreas,2010,39(8):1247-1253.
10 展超,徐海涛,赵亮,等.胰十二指肠切除术后肠内与肠外营养支持的疗效研究[J].实用肿瘤学杂志,2012,26(3):225-226,258.
11 张群华,倪泉兴.代表中国抗癌协会胰腺癌专业委员会胰腺癌2340例临床病例分析[J].中华医学杂志,2004,(3):214-218.
12 Lim JE,Chien MW,Earle CC,et al.Prognostic factors following curative resection for pancreatic adenocarcinoma:a population-based,linked database analysis of 396 patients[J].Ann Sur,2003,237(1):74-85.
13 Haeberle B,Schweinitz D.Treatment of heptoblastoma in the German cooperative pediatric liver tumor studies[J].Front Biosci(Elite Ed),2012,4:493-498.
14 梁宇闯,李卓永,林坚,等.介入栓塞治疗四肢肌间血管瘤的远期疗效[J].中国介入影像与治疗学,2007,4(5):337-339.
15 程祝忠,李迎春,许国辉,等.动脉介入栓塞剂在儿童头颈部血管瘤栓塞治疗的表现及介入治疗中的意义[J].中华妇幼临床医学杂志,2008,4(5):48-51.
16 Müller H,Guadagni S.Regional chemotherapy for carcinoma of the lung[J].Surg Oncol Clin North America,2008,17(4):895-917.
17 朱红霞,刘爽,周翠绮,等.抗凋亡基因Survivin促进细胞转化的作用机制[J].中华医学杂志,2002,82(5):338-340.
18 Kawai S,Suzuki K,Nishio K,et a1.Smoking and serum CA199 levels according to Lewis and secretor genotypes[J].Int J Cancer,2008,123(12):2880-2884.
19 Jia ZL,Zhang HY,Liu C,et a1.Serum tumor markers combined detection applied in the diagnosis of pancreatic cancer[J].Chin Pract Diag Ther,2011,25:130-131.
20 展超,金宇,张玉宝,等.早中期胰腺癌患者血清特异性糖链与CA19-9、CEA检测比较的研究[J].实用肿瘤学杂志,2015,29(1):7-11.
21 赵琳,曹梦晗,王民宪.血清TK1监测对胰腺癌诊断的临床意义[J].中国实验诊断学,2014,11(8):1773-1775.

[1]	王晓雅,肖斌,廖扬,唐荣芝,孙朝晖,李林海. CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析[J]. 实用肿瘤学杂志, 2019, 33(3): 206-210.
[2]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[3]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[4]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[5]	石小康, 丁佑铭, 汪斌, 余斌, 徐雨. UBE2T在原发性肝癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(2): 128-133.
[6]	卢姣云, 张清媛. 实验室标志物在弥漫大B细胞淋巴瘤预后中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 183-187.
[7]	罗干, 易超, 依马木买买提江·阿布拉, 徐林, 尹继炜, 丁伟. Notch信号通路在胰腺癌中的表达及其作用研究[J]. 实用肿瘤学杂志, 2019, 33(1): 1-7.
[8]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[9]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[10]	马健力, 张明辉, 姬宏飞, 徐向英. PD-L1蛋白与CD8⁺TILs联合检测在可切除肺腺癌预后评估中的临床意义[J]. 实用肿瘤学杂志, 2019, 33(1): 40-46.
[11]	杨洪波, 石洁, 叶勇, 李文成, 邓兆平. COL5A2在膀胱癌组织中的表达及其与临床病理特征和预后的相关性分析[J]. 实用肿瘤学杂志, 2019, 33(1): 52-56.
[12]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.
[13]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[14]	肖洪伟, 陈升, 王艳良, 苏学良. 距肛缘≤8 cm的T₁期直肠癌患者经肛门局部切除术的预后及影响因素分析[J]. 实用肿瘤学杂志, 2018, 32(6): 545-549.
[15]	王一然, 黄维, 尹蕾, 刘琳, 周晓平, 牛星鉴, 杨悦, 安巍巍, 姬宏飞. 中性粒细胞与淋巴细胞比值对宫颈癌患者同步放化疗疗效及预后判断的临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 404-409.

新疆313例维汉老年胰腺癌患者预后分析

Prognostic analysis of 313 aged pancreatic cancer patients in hospital treatment between Uygur and Han nationality in Xinjiang area

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价